C. Onal Et Al. , "The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy," JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.6, pp.2426-2432, 2022
Onal, C. Et Al. 2022. The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.6 , 2426-2432.
Onal, C., GÜLTEKİN, M., YAVAŞ, G., Oymak, E., Sari, S., Guler, O. C., ... YİĞİT, E.(2022). The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.6, 2426-2432.
Onal, Cem Et Al. "The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy," JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.6, 2426-2432, 2022
Onal, Cem Et Al. "The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy." JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.6, pp.2426-2432, 2022
Onal, C. Et Al. (2022) . "The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy." JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.6, pp.2426-2432.
@article{article, author={Cem Onal Et Al. }, title={The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy}, journal={JOURNAL OF OBSTETRICS AND GYNAECOLOGY}, year=2022, pages={2426-2432} }